Department of Transplant Surgery, Tampa General Medical Group, Tampa, FL, USA.
Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Am Surg. 2020 Nov;86(11):1592-1595. doi: 10.1177/0003134820942165. Epub 2020 Aug 19.
Studies have shown significant improvement in hepatocellular carcinoma (HCC) recurrence rates after liver transplantation since the united network of organ sharing (UNOS) implementation of a 6-month wait period prior to accrued exception model for end-stage liver disease (MELD) points enacted on October 8, 2015. However, few have examined the impact on HCC dropout rates for patients awaiting liver transplant. Our objective is to evaluate the outcomes of HCC dropout rates before and after the mandatory 6-month wait policy enacted.
We conducted a retrospective cohort study on adult patients added to the liver transplant wait list between January 1, 2012, and March 8, 2019 (n = 767). Information was obtained through electronic medical records and organ procurement and transplant network (OPTN) publicly available national data reports.
In response to the 2015 UNOS-mandated 6-month wait time, dropout rates in the HCC patient population at our center increased from 12% pre-mandate to 20.8% post-mandate This increase was similarly reflected in the national dropout rate, which also increased from 26.3% pre-mandate to 29.0% post-mandate.
From these changes, it is evident that the UNOS mandate achieved its goal of increasing equity of liver organ allocation, but HCC patients are nonetheless dropping off of the wait list at an increased rate and are therefore disadvantaged.
自 2015 年 10 月 8 日美国器官共享联合网络(UNOS)实施累积终末期肝病模型(MELD)评分前 6 个月等待期例外政策以来,研究表明肝癌(HCC)患者在肝移植后复发率显著降低。然而,很少有研究检查这对等待肝移植的 HCC 患者的脱落率的影响。我们的目的是评估在强制性 6 个月等待政策实施前后 HCC 脱落率的结果。
我们对 2012 年 1 月 1 日至 2019 年 3 月 8 日期间加入肝移植等待名单的成年患者进行了回顾性队列研究(n=767)。信息通过电子病历和器官采购与移植网络(OPTN)的公开全国数据报告获得。
为了响应 2015 年 UNOS 的 6 个月等待时间要求,我们中心 HCC 患者人群的脱落率从命令前的 12%增加到命令后的 20.8%。全国范围内的脱落率也同样增加,从命令前的 26.3%增加到命令后的 29.0%。
从这些变化可以明显看出,UNOS 的命令实现了增加肝脏器官分配公平性的目标,但 HCC 患者的等待名单脱落率仍在增加,因此处于不利地位。